Head-to-head · WeighScore
Gatlan vs Spry
The verdict
Gatlan takes it — 57.8/100 to 56.8/100, but only just.
Gatlan grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Gatlan is a telehealth platform offering compounded tirzepatide for weight management, positioned around "doctor-level care, minus the friction." Its standout feature is named clinical leadership — Chief… Spry is close behind and may still be the better fit — see the factor split below.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Gatlan | Spry |
|---|---|---|
| WeighScore | 57.8/100 | 56.8/100 |
| Grade | C | C |
| Scorecard rank | #389 | #409 |
| Semaglutide | Not disclosed | $199/mo (starting dose, compounded) |
| Tirzepatide | Not disclosed | $299/mo (starting dose, compounded) |
| Coverage | 44 states | Coverage not published |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #389 · C
Strengths
- Named Chief Medical Advisor with verifiable credentials — Dr. Robert Lufkin, UCLA/USC professor — rare in this market
- 44 states explicitly listed — you can confirm coverage without starting the sign-up flow
- 'Doctor-Level Care, Minus the Friction' positioning targets buyers wanting premium clinical attention
- Fully online process with concierge delivery and monitoring
- Compounded tirzepatide confirmed
Where it loses points
- Pricing not shown publicly — fully gated behind the sign-up flow
- Unclear whether compounded semaglutide is offered — only tirzepatide is mentioned on the site
- LegitScript certification status not disclosed
- 503A/503B pharmacy partner not named, and designation not specified
- No compounded-medication disclaimer published
Graded #409 · C
Strengths
- Three named co-founders disclosed (Gabriel Mullins, Sara Yoder, Tyler Bowman) — better-than-average transparency
- Pricing shown on the homepage ($199 semaglutide / $299 tirzepatide / $249–$299 peptides) — no full sign-up wall
- Broader range (2 GLP-1s plus 3 anti-aging peptides) appeals to longevity buyers
- No contracts or commitment required
- LegitScript Certified with a public verification link
Where it loses points
- Displays an "FDA Approved" badge though compounded GLP-1s are not FDA-approved finished drugs — potentially misleading
- Intake reviewed by a nurse practitioner, not an MD
- States served not disclosed publicly
- Pharmacy partner not named, and 503A vs 503B designation not specified
- FDA has issued this company a warning letter; the letter is public in FDA's warning-letter database
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.